Therefore, we sought to understand what role ATF4 plays in the ability of cancer cells to adapt to the metabolic requirements of increased glutamine metabolism accompanying the “Warburg effect” by using a GAC inhibitor, CB-839, to disrupt glutaminolysis. This evidence concerns the gene ATF4 and cancer.